Picture of Kainos Laboratories logo

4556 — Kainos Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMicro CapNeutral

Table: Kainos -2024/25 parent results

May 9 (Reuters)- 
          Kainos Laboratories Inc 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           5.31            5.06           5.50          2.70    
               (+4.9 pct)      (+2.7 pct)     (+3.7 pct)    (+1.1 pct) 
  Operating      823 mln         865 mln        850 mln      400 mln   
               (-4.8 pct)      (+5.4 pct)     (+3.2 pct)   (-15.1 pct) 
  Recurring      828 mln         928 mln        850 mln      400 mln   
               (-10.8 pct)     (+8.7 pct)     (+2.6 pct)   (-15.6 pct) 
  Net            641 mln         637 mln        600 mln      280 mln   
               (+0.5 pct)      (+12.3 pct)    (-6.4 pct)   (-19.5 pct) 
  EPS          152.06 yen      152.26 yen     142.33 yen    66.42 yen  
  Ann Div       35.00 yen       32.00 yen      32.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       35.00 yen       32.00 yen      32.00 yen               
  
  NOTE - Kainos Laboratories Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T

Recent news on Kainos Laboratories

See all news